Methylprednisolone Acetate shortage — US supply status & alternatives

Methylprednisolone Acetate

—

🇦🇺 AUST R 12299 · Pfizer Australia Pty Ltd

In supply · Australia

In supply · 🇦🇺 Australia · short in🇺🇸 US🇨🇦 CA

In supply in Australia

Reading today’s signals…

✓ Can I substitute?

Per normal rules

Confirm with prescriber

⇄ Best alternative

None listed

refer to prescriber

◷ Expected back

No estimate

No estimate provided

Product attributes reference data we hold

Active ingredient (INN)	Methylprednisolone Acetate
Therapeutic category	Auto-created by U.S. Food and Drug Administration — Drug Shortages scraper

Controlled substance	No

Marketing-authorisation holders	Pfizer Australia Pty Ltd, Sandoz Inc., SANDOZ CANADA INCORPORATED, PROFESSIONAL VETERINARY LABORATORIES

Registrations on file	8

Patient information leaflet (PIL)	Not on file

Summary of product characteristics (SPC)	Not on file

Trade price 🇦🇺 Australia · awaiting price ingest

🇦🇺 AU

Ex-manufacturer

—

Dispensed (DPMQ)

—

Pack

—

Not yet captured for Australia

Official pricing isn’t on file for this market yet. PBS (Australia), NHS Drug Tariff (United Kingdom) and CMS NADAC (United States) feeds are prioritised; this panel populates automatically once the data lands.

Global API supply base 🇺🇸 FDA Drug Master Files · active Type II

7 API manufacturers

Manufacturers with an active Type II Drug Master File — i.e. cleared to supply this active ingredient into the US market. A proxy for how concentrated the global manufacturing base is.

Low concentration risk

Farmabios SPAEuroapi FrancePharmacia And Upjohn CO Wholly Owned Sub Pfizer INCTianjin Tianyao Pharmaceuticals CO LTDCuria Spain SauSymbiotec Pharmalab Private LTD+1 more

Manufacturing countries: Italy, France, China, Spain, India, Jordan · Source: FDA List of Drug Master Files

Recalls official enforcement reports

🇺🇸

METHYLPREDNISOLONE ACETATE

Sagent Pharmaceuticals · Apr 2024

Class IIdetails ↗

🇺🇸

METHYLPREDNISOLONE ACETATE

Eugia US LLC · Feb 2024

Class IIdetails ↗

🇺🇸

DEPO-MEDROL

Mckesson Medical-Surgical Inc. Corporate Office · Apr 2022

Class IIdetails ↗

🇺🇸

DEPO-MEDROL

Mckesson Medical-Surgical Inc. Corporate Office · Apr 2022

Class IIdetails ↗

🇺🇸

Methylprednisolone Acetate

RXQ Compounding LLC · Sept 2017

Class IIdetails ↗

🇺🇸

Methylprednisolone Acetate

Isomeric Pharmacy Solution, LLC · Apr 2017

Class IIdetails ↗

Verified timeline regulator events

🇨🇦 3 July 2026

medium reported

🇨🇦 3 June 2026

medium reported

🇨🇦 9 Apr 2026

medium reported

🇺🇸 16 June 2022

critical reported

🇺🇸 15 Dec 2021

high reported

🇺🇸 29 May 2013

high reported

Registration recordmarketing-authorisation holders

Registrations & marketing-authorisation holders8 registrations · 4 MA holders

Product	Strength	Form	Market	MA holder	Status
DEPO-MEDROL methylprednisolone acetate	40 mg	—	🇦🇺 AU	Pfizer Australia Pty Ltd	Active
DEPO-NISOLONE methylprednisolone acetate	40 mg	—	🇦🇺 AU	Pfizer Australia Pty Ltd	Active
METHYLPREDNISOLONE ACETATE	80mg/mL	injection	🇺🇸 US	Sandoz Inc.	Active
METHYLPREDNISOLONE ACETATE	40mg/mL	injection	🇺🇸 US	Sandoz Inc.	Active
Methylprednisolone Acetate Injectable Suspension Usp	—	suspension	🇨🇦 CA	SANDOZ CANADA INCORPORATED	Active
Methylprednisolone Acetate Injectable Suspension Usp -	40MG	suspension	🇨🇦 CA	SANDOZ CANADA INCORPORATED	Active
Methylprednisolone Acetate Injectable Suspension Usp -	80MG	suspension	🇨🇦 CA	SANDOZ CANADA INCORPORATED	Active
Methylprednisolone Acetate Sus	40MG	suspension	🇨🇦 CA	PROFESSIONAL VETERINARY LABORATORIES	Active

For health-professional reference only. Mederti aggregates shortage and substitution information from official regulatory sources. It is not clinical advice and data may be incomplete or delayed. Confirm any substitution or supply decision against the primary regulator source, the prescriber, and current clinical references (e.g. AMH) before acting. Terms.